Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2021 | EBMT 2021 highlights: cord blood expansion and artificial intelligence

Meral Beksac • 18 Mar 2021
EBMT 2021

Meral Beksac, MD, Ankara University, Ankara, Turkey, shares her highlights from EBMT 2021, picking out developments in immunotherapy, cord blood expansion and the use of artificial intelligence, and discussing the benefits of attending sessions virtually. This interview took place during the 47th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2021.

Disclosures

Dr Meral Beksac, MD, has participated in advisory boards or speakers bureaus with Amgen, BMS, Celgene, Janssen, Oncopeptides, Sanofi and Takeda.

More from Meral Beksac

3:36
Ex vivo expanded NK cells for hematological cancer immunotherapy
Meral Beksac • 11 Dec 2023
3:52
EMN19: Dara-VCd in patients with multiple myeloma and extramedullary disease
Meral Beksac • 12 Dec 2023
2:16
The value of the early relapse EBMT score in multiple myeloma
Meral Beksac • 28 Sep 2023
1:30
Exploring the role of upfront autoSCT in multiple myeloma
Meral Beksac • 28 Sep 2023
The content of VJHemOnc is intended for healthcare professionals